nmm 22 4500 ICPSR02295 MiAaI m f a u cr mn mmmmuuuu 130521s2004 miu f a eng d (MiAaI)ICPSR02295 MiAaI MiAaI California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 [electronic resource] California Department of Alcohol and Drug Programs 2008-10-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2004 ICPSR 2295 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs of treatment, and (3) the economic value of treatment to society. Data were collected on participants (clients) across four types of treatment programs, or modalities: residential, residential "social model," nonmethadone outpatient, and outpatient methadone (detoxification and maintenance). Data were collected in two phases. In Phase 1, treatment records were abstracted for clients who received treatment or were discharged between October 1, 1991, and September 30, 1992. In Phase 2, these clients were located and recruited for a follow-up interview. The CALDATA design and procedures included elements from several national treatment outcome studies including the Drug Services Research Survey (ICPSR 3393), Services Research Outcomes Study (ICPSR 2691), National Treatment Improvement Evaluation Study (ICPSR 2884), and Drug Abuse Treatment Outcome Study (ICPSR 2258). The record abstract was designed to collect identifying and locating information for interview reference during the personal interviewing phase. The abstract also collected demographic, drug, or alcohol use, and treatment and service information. The follow-up questionnaire covered time periods before, during, and after treatment and focused on topics such as ethnic and educational background, drug and alcohol use, mental and physical health, HIV and AIDS status, drug testing, illegal activities and criminal status, living arrangements and family issues, employment and income, and treatment for drug, alcohol, and mental health problems. Drugs included alcohol, barbiturates, benzodiazepines, cocaine powder, crack, downers, hallucinogens, heroin, illegal methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or preludin, and sedatives/hypnotics. CALDATA was originally known as the California Outcomes Study (COS). Cf.: http://dx.doi.org/10.3886/ICPSR02295.v1 alcohol icpsr inhalants icpsr intervention icpsr marijuana icpsr mental health icpsr methadone icpsr methadone maintenance icpsr methamphetamines icpsr physical health icpsr program evaluation icpsr substance abuse icpsr cocaine icpsr substance abuse treatment icpsr treatment costs icpsr treatment programs icpsr cost effectiveness icpsr drug treatment icpsr drugs icpsr employment icpsr hallucinogens icpsr heroin icpsr illegal activities icpsr SAMHDA XX. California Drug and Alcohol Treatment Assessment (CALDATA) ICPSR XVI.A. Social Indicators, United States California Department of Alcohol and Drug Programs Inter-university Consortium for Political and Social Research. ICPSR (Series) 2295 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02295.v1 nmm 22 4500 ICPSR33041 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33041 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2004 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-09-11 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33041 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33041.v1 over-the-counter drugs icpsr substance abuse icpsr suicide icpsr alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr ICPSR IX. Health Care and Health Facilities SAMHDA VIII. Drug Abuse Warning Network (DAWN) NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33041 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33041.v1 nmm 22 4500 ICPSR33042 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33042 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2005 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-09-11 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33042 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33042.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr SAMHDA VIII. Drug Abuse Warning Network (DAWN) NAHDAP I. National Addiction and HIV Data Archive Program ICPSR IX. Health Care and Health Facilities United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33042 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33042.v1 nmm 22 4500 ICPSR33221 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR33221 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2006 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. 2012-06-12 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 33221 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR33221.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities SAMHDA VIII. Drug Abuse Warning Network (DAWN) NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Inter-university Consortium for Political and Social Research. ICPSR (Series) 33221 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR33221.v1 nmm 22 4500 ICPSR32861 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR32861 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2007 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2012-01-26 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 32861 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR32861.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 32861 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR32861.v1 nmm 22 4500 ICPSR31264 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR31264 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2008 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-01-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 31264 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA’s Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR31264.v3 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 31264 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR31264.v3 nmm 22 4500 ICPSR31921 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR31921 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2009 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-01-24 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 31921 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR31921.v2 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr ICPSR IX. Health Care and Health Facilities SAMHDA VIII. Drug Abuse Warning Network (DAWN) NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 31921 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR31921.v2 nmm 22 4500 ICPSR34083 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR34083 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2010 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-09-27 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 34083 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR34083.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) ICPSR IX. Health Care and Health Facilities United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34083 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34083.v1 nmm 22 4500 ICPSR34565 MiAaI m f a u cr mn mmmmuuuu 130521s2013 miu f a eng d (MiAaI)ICPSR34565 MiAaI MiAaI Drug Abuse Warning Network (DAWN), 2011 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2013-05-02 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2013 ICPSR 34565 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with SAMHSA's Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year. DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report current medications (i.e., medications and pharmaceuticals taken regularly by the patient as prescribed or indicated) that are unrelated to the ED visit. The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals. Cf.: http://dx.doi.org/10.3886/ICPSR34565.v1 alcohol icpsr demographic characteristics icpsr detoxification icpsr drug overdose icpsr drug use icpsr emergency departments icpsr nonprescription drugs icpsr over-the-counter drugs icpsr substance abuse icpsr suicide icpsr NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA VIII. Drug Abuse Warning Network (DAWN) ICPSR IX. Health Care and Health Facilities United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34565 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34565.v1 nmm 22 4500 ICPSR06693 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR06693 MiAaI MiAaI National Comorbidity Survey [electronic resource] Baseline (NCS-1), 1990-1992 Ronald C. Kessler 2008-09-12 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 6693 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Comorbidity Survey: Baseline (NCS-1) was a collaborative epidemiologic investigation designed to study the prevalence and correlates of DSM III-R disorders and patterns and correlates of service utilization for these disorders. The NCS-1 was the first survey to administer a structured psychiatric interview to a nationally representative sample. The survey was carried out in the early 1990s with a household sample of over 8,000 respondents. Subsamples of the original respondents completed the NCS-1 Part II survey and Tobacco Use Supplement. Diagnoses were based on a modified version of the Composite International Diagnostic Interview (the UM-CIDI), which was developed at the University of Michigan for the NCS-1. Drugs covered by this survey include alcohol, tobacco, sedatives, stimulants, tranquilizers, analgesics, inhalants, marijuana/hashish, cocaine, hallucinogens, heroin, nonmedical use of prescription drugs, and polysubstance use. Other items include demographic characteristics, personal and family history of substance use and abuse, substance abuse treatment, data on drug use including recency, frequency, and age at first use, problems resulting from the use of drugs, personal and family history of psychiatric problems, mental health treatment, symptoms of psychiatric disorders, mental health status, HIV risk behaviors, and physical health status. Cf.: http://dx.doi.org/10.3886/ICPSR06693.v6 mental health services icpsr prescription drugs icpsr sedatives icpsr self medication icpsr smoking icpsr psychiatric services icpsr stimulants icpsr alcohol consumption icpsr substance abuse icpsr tobacco products icpsr tobacco use icpsr alcohol icpsr marijuana icpsr mental disorders icpsr mental health icpsr tranquilizers icpsr cocaine icpsr drug use icpsr drugs icpsr hallucinogens icpsr inhalants icpsr health status icpsr heroin icpsr NAHDAP I. National Addiction and HIV Data Archive Program ICPSR XVI.A. Social Indicators, United States FENWAY VI. Studies That Include Heterosexual Populations DSDR III. Health SAMHDA IX. National Comorbidity Survey Kessler, Ronald C. Inter-university Consortium for Political and Social Research. ICPSR (Series) 6693 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06693.v6 nmm 22 4500 ICPSR06843 MiAaI m f a u cr mn mmmmuuuu 130521s1998 miu f a eng d (MiAaI)ICPSR06843 MiAaI MiAaI National Household Survey on Drug Abuse, 1979 [electronic resource] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-06-18 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1998 ICPSR 6843 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about their knowledge of drugs, perceptions of the risks involved, population movement, and sequencing of drug use. Fifty-seven percent of respondents were asked specific questions about their perceptions of the consequences of marijuana and alcohol use. The other 43 percent were asked about heroin use among friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, and household composition. Cf.: http://dx.doi.org/10.3886/ICPSR06843.v3 tranquilizers icpsr youths icpsr tobacco use icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr RCMD I. Crime RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 6843 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06843.v3 nmm 22 4500 ICPSR06845 MiAaI m f a u cr mn mmmmuuuu 130521s1997 miu f a eng d (MiAaI)ICPSR06845 MiAaI MiAaI National Household Survey on Drug Abuse, 1982 [electronic resource] United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse 2008-06-18 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 1997 ICPSR 6845 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include gender, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities. Cf.: http://dx.doi.org/10.3886/ICPSR06845.v2 alcohol icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr marijuana icpsr methamphetamine icpsr prescriptions drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr alcohol abuse icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr NAHDAP I. National Addiction and HIV Data Archive Program RCMD V. Health and Well-Being SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse Inter-university Consortium for Political and Social Research. ICPSR (Series) 6845 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR06845.v2 nmm 22 4500 ICPSR02934 MiAaI m f a u cr mn mmmmuuuu 130521s2000 miu f a eng d (MiAaI)ICPSR02934 MiAaI MiAaI National Household Survey on Drug Abuse, 1998 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-05-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2000 ICPSR 2934 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about personal and family income sources and amounts, substance abuse treatment history, illegal activities, problems resulting from the use of drugs, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Also retained was the section on risk/availability of drugs that was reintroduced in 1996, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997 [ICPSR 2755]) introduced new items that the 1998 NHSDA continued on cigar smoking, people who were present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. Both the 1997 and 1998 NHSDAs had a series of questions that were asked only of respondents aged 12 to 17. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR02934.v4 alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr demographic characteristics icpsr drug abuse icpsr drug use icpsr drugs icpsr hallucinogens icpsr health care icpsr health insurance icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime RCMD V. Health and Well-Being SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 2934 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR02934.v4 nmm 22 4500 ICPSR03262 MiAaI m f a u cr mn mmmmuuuu 130521s2002 miu f a eng d (MiAaI)ICPSR03262 MiAaI MiAaI National Household Survey on Drug Abuse, 2000 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2006-12-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2002 ICPSR 3262 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2000 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained in the 2000 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR03262.v4 drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr alcohol icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr drinking behavior icpsr addiction icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 3262 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR03262.v4 nmm 22 4500 ICPSR03580 MiAaI m f a u cr mn mmmmuuuu 130521s2003 miu f a eng d (MiAaI)ICPSR03580 MiAaI MiAaI National Household Survey on Drug Abuse, 2001 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2006-12-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2003 ICPSR 3580 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2001 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2001 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR03580.v3 drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr alcohol icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr drinking behavior icpsr addiction icpsr drug abuse icpsr drug dependence icpsr NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System SAMHDA I. National Survey on Drug Use and Health (NSDUH) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 3580 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR03580.v3 nmm 22 4500 ICPSR03903 MiAaI m f a u cr mn mmmmuuuu 130521s2004 miu f a eng d (MiAaI)ICPSR03903 MiAaI MiAaI National Survey on Drug Use and Health, 2002 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-03-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2004 ICPSR 3903 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey includes questions concerning treatment for both substance abuse and mental health related disorders. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2002 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2002 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR03903.v4 mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr inhalants icpsr marijuana icpsr NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NAHDAP I. National Addiction and HIV Data Archive Program RCMD V. Health and Well-Being United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 3903 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR03903.v4 nmm 22 4500 ICPSR04138 MiAaI m f a u cr mn mmmmuuuu 130521s2004 miu f a eng d (MiAaI)ICPSR04138 MiAaI MiAaI National Survey on Drug Use and Health, 2003 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-02-28 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2004 ICPSR 4138 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2003 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR04138.v3 marijuana icpsr mental health icpsr mental health services icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr methamphetamine icpsr prescription drugs icpsr inhalants icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr RCMD I. Crime RCMD V. Health and Well-Being NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 4138 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04138.v3 nmm 22 4500 ICPSR04373 MiAaI m f a u cr mn mmmmuuuu 130521s2006 miu f a eng d (MiAaI)ICPSR04373 MiAaI MiAaI National Survey on Drug Use and Health, 2004 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-02-06 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2006 ICPSR 4373 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2004 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR04373.v2 addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tranquilizers icpsr youths icpsr tobacco use icpsr NAHDAP I. National Addiction and HIV Data Archive Program RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being SAMHDA I. National Survey on Drug Use and Health (NSDUH) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 4373 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04373.v2 nmm 22 4500 ICPSR04596 MiAaI m f a u cr mn mmmmuuuu 130521s2006 miu f a eng d (MiAaI)ICPSR04596 MiAaI MiAaI National Survey on Drug Use and Health, 2005 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-22 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2006 ICPSR 4596 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2005 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR04596.v3 substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr addiction icpsr alcohol icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr hallucinogens icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr RCMD V. Health and Well-Being RCMD I. Crime NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NACJD XI. Drugs, Alcohol, and Crime FENWAY I. Fenway Archive Project United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 4596 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR04596.v3 nmm 22 4500 ICPSR21240 MiAaI m f a u cr mn mmmmuuuu 130521s2007 miu f a eng d (MiAaI)ICPSR21240 MiAaI MiAaI National Survey on Drug Use and Health, 2006 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-07 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2007 ICPSR 21240 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2006 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR21240.v5 drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 21240 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR21240.v5 nmm 22 4500 ICPSR23782 MiAaI m f a u cr mn mmmmuuuu 130521s2008 miu f a eng d (MiAaI)ICPSR23782 MiAaI MiAaI National Survey on Drug Use and Health, 2007 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2013-01-04 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2008 ICPSR 23782 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR23782.v3 mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr DSDR III. Health RCMD V. Health and Well-Being NACJD XI. Drugs, Alcohol, and Crime RCMD I. Crime ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 23782 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR23782.v3 nmm 22 4500 ICPSR26701 MiAaI m f a u cr mn mmmmuuuu 130521s2009 miu f a eng d (MiAaI)ICPSR26701 MiAaI MiAaI National Survey on Drug Use and Health, 2008 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2012-12-10 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2009 ICPSR 26701 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR26701.v3 alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr addiction icpsr alcohol icpsr alcohol abuse icpsr RCMD I. Crime DSDR III. Health SAMHDA I. National Survey on Drug Use and Health (NSDUH) ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System RCMD V. Health and Well-Being NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 26701 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR26701.v3 nmm 22 4500 ICPSR29621 MiAaI m f a u cr mn mmmmuuuu 130521s2010 miu f a eng d (MiAaI)ICPSR29621 MiAaI MiAaI National Survey on Drug Use and Health, 2009 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies 2012-11-16 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2010 ICPSR 29621 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR29621.v3 addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographics icpsr depression icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pain relievers icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) NACJD XI. Drugs, Alcohol, and Crime NAHDAP I. National Addiction and HIV Data Archive Program DSDR III. Health RCMD V. Health and Well-Being ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies Inter-university Consortium for Political and Social Research. ICPSR (Series) 29621 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR29621.v3 nmm 22 4500 ICPSR32722 MiAaI m f a u cr mn mmmmuuuu 130521s2011 miu f a eng d (MiAaI)ICPSR32722 MiAaI MiAaI National Survey on Drug Use and Health, 2010 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2012-11-21 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2011 ICPSR 32722 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2010 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR32722.v3 youths icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographics icpsr depression icpsr drinking behavior icpsr drug abuse icpsr addiction icpsr sedatives icpsr pregnancy icpsr prescription drugs icpsr smoking icpsr stimulants icpsr tobacco use icpsr tranquilizers icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pain relievers icpsr drug use icpsr drugs icpsr drug dependence icpsr drug treatment icpsr substance abuse icpsr substance abuse treatment icpsr NACJD XI. Drugs, Alcohol, and Crime RCMD I. Crime SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being DSDR III. Health NAHDAP I. National Addiction and HIV Data Archive Program ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 32722 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR32722.v3 nmm 22 4500 ICPSR34481 MiAaI m f a u cr mn mmmmuuuu 130521s2012 miu f a eng d (MiAaI)ICPSR34481 MiAaI MiAaI National Survey on Drug Use and Health, 2011 [electronic resource] United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality 2013-03-28 Ann Arbor, Mich. Inter-university Consortium for Political and Social Research [distributor] 2012 ICPSR 34481 Numeric Title from ICPSR DDI metadata of 2013-05-21. AVAILABLE. This study is freely available to the general public. Also available as downloadable files. The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. Cf.: http://dx.doi.org/10.3886/ICPSR34481.v1 addiction icpsr alcohol icpsr alcohol abuse icpsr alcohol consumption icpsr amphetamines icpsr barbiturates icpsr cocaine icpsr controlled drugs icpsr crack cocaine icpsr demographic characteristics icpsr depression (psychology) icpsr drinking behavior icpsr drug abuse icpsr drug dependence icpsr drug treatment icpsr drug use icpsr drugs icpsr employment icpsr hallucinogens icpsr health care icpsr heroin icpsr households icpsr income icpsr inhalants icpsr marijuana icpsr mental health icpsr mental health services icpsr methamphetamine icpsr pregnancy icpsr prescription drugs icpsr sedatives icpsr smoking icpsr stimulants icpsr substance abuse icpsr substance abuse treatment icpsr tobacco use icpsr tranquilizers icpsr youths icpsr ICPSR XVII.E. Social Institutions and Behavior, Crime and the Criminal Justice System DSDR III. Health NAHDAP I. National Addiction and HIV Data Archive Program SAMHDA I. National Survey on Drug Use and Health (NSDUH) RCMD V. Health and Well-Being RCMD I. Crime NACJD XI. Drugs, Alcohol, and Crime United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality Inter-university Consortium for Political and Social Research. ICPSR (Series) 34481 Access restricted ; authentication may be required: http://dx.doi.org/10.3886/ICPSR34481.v1